Patterns of Child and Adolescent Psychiatric Admissions Before and After the Onset of the COVID-19 Pandemic: Take Home Messages from a Clinical Population.

IF 0.5 4区 医学 Q4 PHARMACOLOGY & PHARMACY
Ozalp Ekinci, Ibrahim Adak, Ipek Suzer Gamli, Gulhan Orekici Temel, Gulser Taylan, Zeynep Ece Toksoy, Sukrucan Kocabas, Cagla Boztepe, Sevcan Karakoc, Oguz Bilal Karakus
{"title":"Patterns of Child and Adolescent Psychiatric Admissions Before and After the Onset of the COVID-19 Pandemic: Take Home Messages from a Clinical Population.","authors":"Ozalp Ekinci, Ibrahim Adak, Ipek Suzer Gamli, Gulhan Orekici Temel, Gulser Taylan, Zeynep Ece Toksoy, Sukrucan Kocabas, Cagla Boztepe, Sevcan Karakoc, Oguz Bilal Karakus","doi":"10.5152/pcp.2024.23811","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>: This study from Istanbul aimed to compare the child and adolescent psychiatric admissions and diagnosis rates between the first 3 months of the pandemic, the previous 3 months in the same year, and the same months in the previous year.</p><p><strong>Methods: </strong>: Children and adolescents were grouped according to the admission dates. Group A, between March 11 and June 1, 2020; Group B, between January 1 and March 11, 2020; and Group C, between March 11 and June 1, 2019. Only clinical interviews and diagnoses according to Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version (K-SADS-PL) interview were included.</p><p><strong>Results: </strong>: Autism spectrum disorder (ASD), obsessive-compulsive disorder (OCD)/tic disorder, and intellectual disability (ID) diagnoses were higher in group A than in groups B and C (for ASD, 6.4%, 4.3%, and 3.6%; for OCD/tic disorder, 2.9%, 1.8%, 1.7%; for ID, 3.7%, 2.5%, and 2.1%, respectively) (<i>P</i> < .001). Attention-deficit hyperactivity disorder (ADHD) diagnosis was higher in group A than in only group B (59.8% and 49.7%, respectively) (<i>P</i> < 0.001). Depression was higher in group A than in only group C (4.1% and 2.2%, respectively) (<i>P</i> < .001). Conduct disorder (CD) diagnosis was lower in group A than in only group B (3.6% and 6.4%, respectively) (<i>P</i> < .05).</p><p><strong>Conclusion: </strong>: Child psychiatry diagnosis rates were found to change significantly during the initial phase of the pandemic period. Among the referrals, ASD, OCD, Tic disorder, ID, ADHD, and depression admissions were significantly higher. The rate of pediatric neurodevelopmental disorders, particularly ASD, increased during the initial phase of the COVID-19 pandemic.</p>","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":null,"pages":null},"PeriodicalIF":0.5000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11500439/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatry and Clinical Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5152/pcp.2024.23811","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: : This study from Istanbul aimed to compare the child and adolescent psychiatric admissions and diagnosis rates between the first 3 months of the pandemic, the previous 3 months in the same year, and the same months in the previous year.

Methods: : Children and adolescents were grouped according to the admission dates. Group A, between March 11 and June 1, 2020; Group B, between January 1 and March 11, 2020; and Group C, between March 11 and June 1, 2019. Only clinical interviews and diagnoses according to Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version (K-SADS-PL) interview were included.

Results: : Autism spectrum disorder (ASD), obsessive-compulsive disorder (OCD)/tic disorder, and intellectual disability (ID) diagnoses were higher in group A than in groups B and C (for ASD, 6.4%, 4.3%, and 3.6%; for OCD/tic disorder, 2.9%, 1.8%, 1.7%; for ID, 3.7%, 2.5%, and 2.1%, respectively) (P < .001). Attention-deficit hyperactivity disorder (ADHD) diagnosis was higher in group A than in only group B (59.8% and 49.7%, respectively) (P < 0.001). Depression was higher in group A than in only group C (4.1% and 2.2%, respectively) (P < .001). Conduct disorder (CD) diagnosis was lower in group A than in only group B (3.6% and 6.4%, respectively) (P < .05).

Conclusion: : Child psychiatry diagnosis rates were found to change significantly during the initial phase of the pandemic period. Among the referrals, ASD, OCD, Tic disorder, ID, ADHD, and depression admissions were significantly higher. The rate of pediatric neurodevelopmental disorders, particularly ASD, increased during the initial phase of the COVID-19 pandemic.

COVID-19 大流行前后儿童和青少年精神病入院模式:来自临床人群的启示。
背景: :这项来自伊斯坦布尔的研究旨在比较大流行病发生后头三个月、同年前三个月和前一年同月的儿童和青少年精神病入院率和诊断率:根据入院日期对儿童和青少年进行分组。A组,2020年3月11日至6月1日;B组,2020年1月1日至3月11日;C组,2019年3月11日至6月1日。仅包括临床访谈和根据 Kiddie 情感障碍和精神分裂症--现在和终生版本(K-SADS-PL)访谈做出的诊断:自闭症谱系障碍(ASD)、强迫症(OCD)/抽动障碍和智障(ID)的诊断率在 A 组高于 B 组和 C 组(ASD 分别为 6.4%、4.3% 和 3.6%;强迫症/抽动障碍分别为 2.9%、1.8% 和 1.7%;智障分别为 3.7%、2.5% 和 2.1%)(P < .001)。被诊断为注意力缺陷多动障碍(ADHD)的 A 组人数高于 B 组(分别为 59.8%和 49.7%)(P < 0.001)。抑郁症患者在 A 组的比例(分别为 4.1%和 2.2%)高于仅在 C 组的比例(P < 0.001)。行为障碍 (CD) 的诊断率在 A 组低于 B 组(分别为 3.6% 和 6.4%)(P < .05):儿童精神病学诊断率在大流行初期有明显变化。在转诊病例中,ASD、强迫症、抽搐症、ID、多动症和抑郁症的入院率明显较高。在 COVID-19 大流行的初期阶段,儿科神经发育障碍,尤其是 ASD 的发病率有所上升。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Psychiatry and Clinical Psychopharmacology
Psychiatry and Clinical Psychopharmacology Medicine-Psychiatry and Mental Health
CiteScore
1.00
自引率
14.30%
发文量
0
期刊介绍: Psychiatry and Clinical Psychopharmacology aims to reach a national and international audience and will accept submissions from authors worldwide. It gives high priority to original studies of interest to clinicians and scientists in applied and basic neurosciences and related disciplines. Psychiatry and Clinical Psychopharmacology publishes high quality research targeted to specialists, residents and scientists in psychiatry, psychology, neurology, pharmacology, molecular biology, genetics, physiology, neurochemistry, and related sciences.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信